English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 17, 2026

J&J and AbbVie CEOs receive pay increases exceeding $30 million in 2025
+ Pharmaceuticals
Patient Daily | Mar 17, 2026

BridgeBio reports positive Phase 3 results for limb-girdle muscular dystrophy drug
+ Pharmaceuticals
Patient Daily | Mar 17, 2026

Eli Lilly warns of safety risks in compounded tirzepatide formulations
+ Pharmaceuticals
Patient Daily | Mar 17, 2026

Biogen, Sarepta, and Edgewise present new data at Muscular Dystrophy Association 2026 conference
+ Pharmaceuticals
Patient Daily | Mar 17, 2026

Los Angeles aims to become a leading global life sciences hub
+ Pharmaceuticals
Patient Daily | Mar 17, 2026

Industry questions FDA’s data-sharing guidance for cell and gene therapy sector
+ Pharmaceuticals
Patient Daily | Mar 17, 2026

Biopharma job postings rise in February, marking first annual increase since 2022
+ Pharmaceuticals
Patient Daily | Mar 17, 2026

Lurie Autism Institute names Huda Zoghbi as first recipient of autism research prize

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes